AbbVie Puts Humira on TrumpRx at Steep Discount as Tariff Threat Solidifies

PartnershipHumiraNegative

AI Analysis

Summary

AbbVie agreed to offer Humira at an 86% discount through TrumpRx as part of a White House deal to avoid tariffs on pharmaceutical products. The agreement comes following the president's announcement of potential levies up to 100% on pharma imports.

Outcome Details

Humira pricing agreement with White House to avoid tariffs

Importance:5/10

Sentiment:

-0.30

pricingtariffsgovernment relationsWhite Housediscount pricing

Related Companies

$ABBV

Read the original article

Published by BioSpace on April 7, 2026 1:42 PM

Read Original